BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23652866)

  • 1. The use of an intrathecal pump to manage intractable cancer pain in a pediatric patient: a case report.
    Bengali R; Huang MS; Gulur P
    J Pediatr Hematol Oncol; 2014 Apr; 36(3):e162-4. PubMed ID: 23652866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intractable cancer pain: a new technique for attack in a patient with an implanted intrathecal infusion pump.
    Kowal AG; Staats PS
    Reg Anesth; 1997; 22(6):584. PubMed ID: 9425980
    [No Abstract]   [Full Text] [Related]  

  • 3. Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain.
    Deer TR; Smith HS; Burton AW; Pope JE; Doleys DM; Levy RM; Staats PS; Wallace MS; Webster LR; Rauck RL; Cousins M;
    Pain Physician; 2011; 14(3):E283-312. PubMed ID: 21587338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal morphine pump for neuropathic cancer pain: a case report.
    Gogia V; Chaudhary P; Ahmed A; Khurana D; Mishra S; Bhatnagar S
    Am J Hosp Palliat Care; 2012 Aug; 29(5):409-11. PubMed ID: 21868426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal narcotic infusion pumps for intractable pain of chronic pancreatitis: a pilot series.
    Kongkam P; Wagner DL; Sherman S; Fogel EL; Whittaker SC; Watkins JL; McHenry L; Lehman GA
    Am J Gastroenterol; 2009 May; 104(5):1249-55. PubMed ID: 19367269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Infusaid pump in the management of intractable cancer pain.
    Bryant DD; DeWitty RL; Dennis GC
    J Natl Med Assoc; 1987 Mar; 79(3):305-11. PubMed ID: 3573060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Median arcuate ligament syndrome--a novel treatment using an intrathecal morphine pump to relieve intractable visceral pain.
    Guttman OT; Rosenblatt MA; Mims T
    Pain Pract; 2008; 8(2):133-7. PubMed ID: 18194349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal catheter-syringe adaptor for short-term intrathecal analgesia with an externalized pump: a case report.
    Wilkes D; Cook M; Solanki D
    Pain Physician; 2010; 13(2):151-6. PubMed ID: 20309381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in psychosocial outcomes in chronic pain patients receiving intrathecal morphine infusions.
    Duse G; DaviĆ  G; White PF
    Anesth Analg; 2009 Dec; 109(6):1981-6. PubMed ID: 19923529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Continuous intrathecal opiate therapy with a portable drug pump in cancer pain].
    Motsch J; Bleser W; Ismaily AJ; Distler L
    Anasth Intensivther Notfallmed; 1988 Oct; 23(5):271-5. PubMed ID: 2907271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost utilization analysis of intrathecal therapy for refractory cancer pain: identifying factors associated with cost benefit.
    Brogan SE; Winter NB; Abiodun A; Safarpour R
    Pain Med; 2013 Apr; 14(4):478-86. PubMed ID: 23461787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous nerve transection for the management of intractable upper extremity pain caused by invasive squamous cell carcinoma.
    Turnbull JH; Gebauer SL; Miller BL; Barbaro NM; Blanc PD; Schumacher MA
    J Pain Symptom Manage; 2011 Jul; 42(1):126-33. PubMed ID: 21306862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SynchroMed II intrathecal pump memory errors due to repeated magnetic resonance imaging.
    Kosturakis A; Gebhardt R
    Pain Physician; 2012; 15(6):475-7. PubMed ID: 23159963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intrathecal implantable infusion pumps in the treatment of refractory pain--report of 3 cases].
    Wang RZ; Tao W; Ren ZY; Su CB; Yang Y; Zhang B; Ma WB; Yang Z; Gong ZY; Ye TH
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1746-9. PubMed ID: 15569443
    [No Abstract]   [Full Text] [Related]  

  • 15. Labour pain management in a parturient with an implanted intrathecal pump.
    Tarshis J; Zuckerman JE; Katz NP; Segal S; Mushlin PS
    Can J Anaesth; 1997 Dec; 44(12):1278-81. PubMed ID: 9429046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing intrathecal drug delivery (ITDD) in cancer patients.
    Shah R; Baqai-Stern A; Gulati A
    Curr Pain Headache Rep; 2015 Jun; 19(6):20. PubMed ID: 26021753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal hydromorphone for intractable nonmalignant pain: a retrospective study.
    Du Pen S; Du Pen A; Hillyer J
    Pain Med; 2006; 7(1):10-5. PubMed ID: 16533191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable intrathecal pumps for chronic pain: highlights and updates.
    Knight KH; Brand FM; Mchaourab AS; Veneziano G
    Croat Med J; 2007 Feb; 48(1):22-34. PubMed ID: 17309136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous intrathecal hydromorphone and clonidine for intractable cancer pain.
    Coombs DW; Saunders RL; Fratkin JD; Jensen LE; Murphy CA
    J Neurosurg; 1986 Jun; 64(6):890-4. PubMed ID: 2422332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal ziconotide for chronic pain.
    Bonicalzi V; Canavero S
    JAMA; 2004 Oct; 292(14):1681-2; author reply 1682. PubMed ID: 15479926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.